GlassScriptPhysician profile
Cameron Lindler
NPI 1538757935
$6,477.05
in general payments reported to CMS, 2019-2025
21 companies · $39.81 in 2025
The $39.81 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $671 · 2022: $2,805 · 2023: $2,132 · 2024: $829 · 2025: $39.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,000.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,448.27 | 2022-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $810.92 | 2023-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $543.51 | 2021-2023 | Relistor |
| Vertos Medical, INC. | $480.54 | 2021-2022 | |
| Nevro Corp. | $385.56 | 2022-2024 | Senza |
| Forte Bio-Pharma LLC | $227.61 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $121.15 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $81.22 | 2022 | |
| Amgen INC. | $71.05 | 2021 | |
| Lundbeck LLC | $51.44 | 2022 | |
| Inari Medical, INC. | $40.92 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Scilex Pharmaceuticals INC. | $40.14 | 2022 | |
| Arbor Pharmaceuticals, INC. | $27.35 | 2021 | |
| Biodelivery Sciences International, INC. | $26.87 | 2021 | |
| Abbvie INC. | $25.58 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $19.39 | 2025 | |
| Nalu Medical, INC. | $18.92 | 2021 | |
| Spinal Simplicity, LLC | $18.72 | 2024 | Ha Minuteman G3-R |
| Lilly USA, LLC | $14.40 | 2021 | |
| Hikma Pharmaceuticals USA | $13.49 | 2021 | |
| Saluda Medical Americas, INC. | $10.00 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Lindler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.